M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer
Authors
Keywords
-
Journal
Pharmaceutics
Volume 13, Issue 9, Pages 1493
Publisher
MDPI AG
Online
2021-09-18
DOI
10.3390/pharmaceutics13091493
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Co-delivery of Salinomycin and Curcumin for Cancer Stem Cell Treatment by Inhibition of Cell Proliferation, Cell Cycle Arrest, and Epithelial–Mesenchymal Transition
- (2021) Yongmei Zhao et al. Frontiers in Chemistry
- Inhibiting RRM2 to enhance the anticancer activity of chemotherapy
- (2020) Yaqiong Zhan et al. BIOMEDICINE & PHARMACOTHERAPY
- Metastasis-on-a-chip reveals adipocyte-derived lipids trigger cancer cell migration via HIF-1α activation in cancer cells
- (2020) Jieun Seo et al. BIOMATERIALS
- Synergistic ferroptosis and macrophage re-polarization using engineering exosome-mimic M1 nanovesicles for cancer metastasis suppression
- (2020) Ping Li et al. CHEMICAL ENGINEERING JOURNAL
- Organic Semiconducting Pro-nanostimulants for Near-Infrared Photoactivatable Cancer Immunotherapy
- (2019) Jingchao Li et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Chemoresistance in Pancreatic Cancer
- (2019) Zeng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis
- (2019) Liuwan Zhao et al. JOURNAL OF CONTROLLED RELEASE
- The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2019) Akram Pourshams et al. Lancet Gastroenterology & Hepatology
- Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo
- (2018) Shuhei Shinoda et al. Oncotarget
- Exosomes: The next generation of endogenous nanomaterials for advanced drug delivery and therapy
- (2018) Wen Liao et al. Acta Biomaterialia
- Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery
- (2018) Sophia Antimisiaris et al. Pharmaceutics
- Exosomes from M1-Polarized Macrophages Potentiate the Cancer Vaccine by Creating a Pro-inflammatory Microenvironment in the Lymph Node
- (2017) Lifang Cheng et al. MOLECULAR THERAPY
- Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters
- (2017) Patricia Dauer et al. PANCREATOLOGY
- Imidazole-modified deferasirox encapsulated polymeric micelles as pH-responsive iron-chelating nanocarrier for cancer chemotherapy
- (2017) Man Theerasilp et al. RSC Advances
- Gene Expression Levels as Predictive Markers of Outcome in Pancreatic Cancer after Gemcitabine-Based Adjuvant Chemotherapy
- (2015) Hayato Fujita et al. NEOPLASIA
- A comprehensive overview of exosomes as drug delivery vehicles — Endogenous nanocarriers for targeted cancer therapy
- (2014) Kasper Bendix Johnsen et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The effect of hyaluronic acid functionalized carbon nanotubes loaded with salinomycin on gastric cancer stem cells
- (2014) Hong-juan Yao et al. BIOMATERIALS
- Quasi-spherical microwells on superhydrophobic substrates for long term culture of multicellular spheroids and high throughput assays
- (2014) Tianqing Liu et al. BIOMATERIALS
- Quantitative synchrotron X-ray fluorescence study of the penetration of transferrin-conjugated gold nanoparticles inside model tumour tissues
- (2014) Tianqing Liu et al. Nanoscale
- ABC transporters in CSCs membranes as a novel target for treating tumor relapse
- (2014) Laura Zinzi et al. Frontiers in Pharmacology
- A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy
- (2013) Yanhua Tian et al. BIOMATERIALS
- An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma
- (2012) Sarah B. Fisher et al. CANCER
- Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition
- (2012) KARL QUINT et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Developments in metastatic pancreatic cancer: Is gemcitabine still the standard?
- (2012) Jie-Er Ying WORLD JOURNAL OF GASTROENTEROLOGY
- Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer
- (2011) Yi Miao ONCOLOGY REPORTS
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Effect of Food, Type of Food, and Time of Food Intake on Deferasirox Bioavailability: Recommendations for an Optimal Deferasirox Administration Regimen
- (2008) Renzo Galanello et al. JOURNAL OF CLINICAL PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started